Calbindin-D28K acts as a calcium-dependent chaperone suppressing α-synuclein fibrillation in vitro
暂无分享,去创建一个
Vladimir N. Uversky | Wenbo Zhou | V. Uversky | A. Fink | Anthony L. Fink | Chunmei Long | Wenbo Zhou | Chunmei Long
[1] V. Buchman,et al. Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease , 2003, Neuropharmacology.
[2] B. Hyman,et al. Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity , 1998, Journal of neuropathology and experimental neurology.
[3] Vladimir N. Uversky,et al. Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation , 2007 .
[4] Ralf Langen,et al. Structure of membrane-bound α-synuclein studied by site-directed spin labeling , 2004 .
[5] A. Abeliovich,et al. DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits α-Synuclein Aggregate Formation , 2004, PLoS biology.
[6] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[7] Michel Goedert,et al. Identification of two distinct synucleins from human brain , 1994, FEBS letters.
[8] P. Lansbury,et al. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. , 2002, Biochemistry.
[9] H. Erdjument-Bromage,et al. Parkinson's disease-associated alpha-synuclein is a calmodulin substrate. , 2003, The Journal of biological chemistry.
[10] Vladimir N Uversky,et al. A Protein-Chameleon: Conformational Plasticity of α-Synuclein, a Disordered Protein Involved in Neurodegenerative Disorders , 2003, Journal of biomolecular structure & dynamics.
[11] A. Norman,et al. Ontogeny of the calcium binding protein calbindin D-28k in the rat nervous system , 2004, Anatomy and Embryology.
[12] V. Uversky,et al. Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease , 2001, FEBS letters.
[13] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[14] Makoto Hashimoto,et al. β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.
[15] B. Hyman,et al. Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations. , 2001, Journal of neurochemistry.
[16] A. Jonas,et al. Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.
[17] Vladislav Yu Orekhov,et al. Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form. , 2007, Biochimie.
[18] V. Uversky,et al. Natively unfolded C‐terminal domain of caldesmon remains substantially unstructured after the effective binding to calmodulin , 2003, Proteins.
[19] V. Uversky,et al. Stabilization of Partially Folded Conformation during α-Synuclein Oligomerization in Both Purified and Cytosolic Preparations* , 2001, The Journal of Biological Chemistry.
[20] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[21] R A Crowther,et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Perrin,et al. Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. , 2000, The Journal of biological chemistry.
[23] D. Clayton,et al. Synucleins in synaptic plasticity and neurodegenerative disorders , 1999, Journal of neuroscience research.
[24] P. Mcgeer,et al. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K , 1990, Brain Research.
[25] R. Nussbaum,et al. Lipid Droplet Binding and Oligomerization Properties of the Parkinson's Disease Protein α-Synuclein* , 2002, The Journal of Biological Chemistry.
[26] V. Uversky,et al. Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.
[27] Min Zhu,et al. Lipid Binding Inhibits α-Synuclein Fibril Formation* , 2003, The Journal of Biological Chemistry.
[28] P. Gaspar,et al. Sparing of the dopaminergic neurons containing Calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice , 1994, Neuroscience.
[29] A. Parent,et al. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. , 1991, Neuroreport.
[30] E. Masliah,et al. beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. , 2001, Neuron.
[31] Vladimir N Uversky,et al. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. , 2007, Journal of neurochemistry.
[32] Mark A. Wilson,et al. The oxidation state of DJ-1 regulates its chaperone activity toward α-synuclein , 2006 .
[33] B. Hyman,et al. Characterization of the Precursor Protein of the Non-Aβ Component of Senile Plaques (NACP) in the Human Central Nervous System , 1996, Journal of neuropathology and experimental neurology.
[34] E. Masliah,et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] Seung-Jae Lee,et al. Membrane-bound α-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form* , 2002, The Journal of Biological Chemistry.
[36] A. Sigalov,et al. The intrinsically disordered cytoplasmic domain of the T cell receptor zeta chain binds to the nef protein of simian immunodeficiency virus without a disorder-to-order transition. , 2008, Biochemistry.
[37] S. Christakos,et al. Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations, and molecular biology. , 1989, Endocrine reviews.
[38] P. Lansbury,et al. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.
[39] P. Højrup,et al. α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356* , 1999, The Journal of Biological Chemistry.
[40] A. Sigalov. Signaling chain homooligomerization (SCHOOL) model. , 2008, Advances in experimental medicine and biology.
[41] David F. Clayton,et al. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.
[42] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[43] Min Zhu,et al. Lipid binding inhibits alpha-synuclein fibril formation. , 2003, The Journal of biological chemistry.
[44] V. Buchman,et al. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. , 2003, Neuropharmacology.
[45] M. Gross,et al. Physiology and biochemistry of vitamin D-dependent calcium binding proteins. , 1990, The American journal of physiology.
[46] M. Celio,et al. Calbindin D-28k and parvalbumin in the rat nervous system , 1990, Neuroscience.
[47] H. Erdjument-Bromage,et al. Parkinson's Disease-associated α-Synuclein Is a Calmodulin Substrate* , 2003, The Journal of Biological Chemistry.
[48] Jing Zhang,et al. Identification of Novel Proteins Associated with Both α-Synuclein and DJ-1*S , 2007, Molecular & Cellular Proteomics.
[49] Ralf Langen,et al. Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[50] B. A. Brooks,et al. Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells a , 1992, Annals of the New York Academy of Sciences.
[51] G. Petsko,et al. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. , 2006, Journal of molecular biology.
[52] A. Goldberg,et al. PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone , 2000, Nature Cell Biology.
[53] Michel Goedert,et al. Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.
[54] Reinhard Jahn,et al. A Broken α-Helix in Folded α-Synuclein* , 2003, The Journal of Biological Chemistry.
[55] J. Trojanowski,et al. Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein , 2003, Science.
[56] P. P. Lele,et al. Sensory nerves of the cornea and cutaneous sensibility. , 1959, Experimental neurology.
[57] P. Worley,et al. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions , 1999, Nature Genetics.
[58] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[59] David F. Clayton,et al. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.
[60] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[61] P. Lansbury,et al. Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease? , 2000, Nature Cell Biology.
[62] R. Gainetdinov,et al. Experimental Genetic Approaches to Addiction , 2002, Neuron.
[63] J. T. Penniston,et al. Immunocytochemical localization of the plasma membrane calcium pump, calbindin-D28k, and parvalbumin in Purkinje cells of avian and mammalian cerebellum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[64] S. Scarlata,et al. Membrane binding and self-association of alpha-synucleins. , 2001, Biochemistry.
[65] P. Lansbury,et al. Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. , 2002, Biochemistry.
[66] P. Worley,et al. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. , 1999, Nature genetics.
[67] Sebastian Doniach,et al. Biophysical Properties of the Synucleins and Their Propensities to Fibrillate , 2002, The Journal of Biological Chemistry.
[68] C. Ballard,et al. Neuroleptic drugs in dementia: benefits and harm , 2006, Nature Reviews Neuroscience.
[69] T. Craig,et al. Changes in structure and stability of calbindin-D(28K) upon calcium binding. , 2004, Analytical biochemistry.
[70] R. Scheller,et al. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[71] B. Hyman,et al. Interaction of α‐synuclein and synphilin‐1: effect of Parkinson's disease‐associated mutations , 2001 .